Tarsus Pharmaceuticals

Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapeutic candidates to address unmet needs in eye care and other diseases. They generate revenue primarily through the development and potential commercialization of their lead product candidate, TP-03, aimed at treating Demodex blepharitis. Founded in 2016, Tarsus has made significant strides in clinical trials and regulatory processes, positioning itself as a key player in the ophthalmic pharmaceutical industry.

Recent Posts by Tarsus Pharmaceuticals

1-20 of 197